Traces of medicines in water bodies also affect fish. Medicines used to treat depression have particularly strong effects. This has been demonstrated by research carried out as part of the ‘Effect Network in Water Research’ project by the Universities of Heidelberg and Tübingen, as well as the Karlsruhe Institute of Technology, which is investigating the effects of medicines and food additives in the aquatic environment.
As behavioural studies with zebrafish and brown trout show, antidepressants have a particularly strong effect: the study examined fluoxetine and citalopram, which are used in large quantities to treat depression. Even at exceptionally low, environmentally relevant concentrations, these neuroactive substances led to behavioural changes. For instance, zebrafish embryos react very sensitively when the lighting in their environment changes. They swim frantically back and forth and try to hide. Under the influence of the antidepressants, this behaviour changed: the higher the concentration of the two drugs in the water, the less the fish exhibited this protective reflex when the lighting changed. The fish had lost their natural response to stress.
The scientists were also able to demonstrate effects with an antidiabetic drug used to treat type 2 diabetes. Experiments on brown trout showed that the active ingredient, in concentrations such as those found in rivers, caused the fish to store more carbohydrates in their livers and lose weight. Furthermore, the bacterial composition in the animals’ intestines changed: for example, there was an increase in bacterial species that can weaken the fish.
References:
University of Heidelberg, Eberhard Karls University of Tübingen, Karlsruhe Institute of Technology (KIT)
Press release: University of Heidelberg